TGGI Stock | News | Quote | Stock Forum | Monday, December 2,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$TGGI Trans Global Group, Inc. TGGI Company Overview 

Trans Global Group, Inc. TGGI Current Price and Quotes
Last Price 0.0002
Previous Close 0.0002 Open 0.0002
Daily Range 0.0002 - 0.0001 52wk Range 0.0014 - 0.0001
Volume 48,791,350 Dividend N/A
Average Vol (3m) 100,228,985 Yield N/A

TGGI Stock Message Board http://investorshangout.com/search?q=TGGI&...mp;yt1=Go!

Last Updated: Monday, December 2, 2013 01:20:02 AM

Trans Global Group, Inc. TGGI

Company Updated Profile
Company Information

7401 Wiles Road
Suite 318
Coral Springs, FL 33067

Website: http://www.Transglobalgroupinc.com
Phone: 954-509-3749
Email: info@transglobalgroupinc.com

Trans Global Group, Inc. TGGI
Trans Global Group, Inc. is a Green company in the Renewable Energy and Solar Energy sector. The Company and its subsidiary strive to use science and technology to reduce homeowner?s and business? energy consumption, lower their carbon footprint, increase the efficiency of their energy products and reduce energy costs. TGGI is committed to improving the environment through the products offered through its subsidiary. We provide an economically and environmentally friendly viable Energy alternat...



Trans Global Group, Inc. TGGI
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o Oct 05, 2007
Audited Financials Not Available
Latest Report Sep 30, 2013 Quarterly Report
CIK 0000312979
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 3433 - Heating equipment, except electric
Business Status Development Stage Company a/o May 08, 2009
Incorporated In: NV, USA
Year of Inc. 1993
Employees 3 a/o May 02, 2011
Company Officers/Contacts

Chris Clarke CEO, President
Company Directors

Not Available
Company Notes

Formerly=Teletek, Inc. until 10-07
Service Providers

Auditor/Accountant
MaloneBailey, LLP
10350 Richmond Ave.
Suite 800
Houston, TX, 77042
United States

Legal Counsel
George J.Tate, PLLC
130 Main Street
Abbeville, LA, 70511
United States

Investor Relations Firm
Not Available

Trans Global Group, Inc. TGGI
TGGI Security Details

Share Structure

Market Value1 $705,490 a/o Nov 29, 2013
Shares Outstanding 3,527,452,331 a/o Nov 20, 2013
Float 3,447,452,631 a/o Nov 20, 2013
Authorized Shares 3,600,000,000 a/o Oct 22, 2013
Par Value  0.0001
Shareholders

Shareholders of Record 252 a/o Sep 30, 2011
Security Notes

New Issue=9-79 15,000,000 shs at 10 Cents by S.W. Devanney & Co., Inc.
Capital Change=shs decreased by 1 for 400 split. Pay date=10/15/2007.

Trans Global Group, Inc. TGGI Financials

Trans Global Group, Inc. TGGI Recent News

TGGI Trans Global Group, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=TGGI&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/TGGI/quote
Stock Chart http://www.otcmarkets.com/stock/TGGI/chart
Company Info http://www.otcmarkets.com/stock/TGGI/company-info
Recent News http://www.otcmarkets.com/stock/TGGI/news
Financials http://www.otcmarkets.com/stock/TGGI/financials
Filings and Disclosure http://www.otcmarkets.com/stock/TGGI/filings
Short Sales http://www.otcmarkets.com/stock/TGGI/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/TGGI/insider-transactions
Research Reports http://www.otcmarkets.com/stock/TGGI/research
Summary http://finance.yahoo.com/q?s=TGGI
Historical Prices http://finance.yahoo.com/q/hp?s=TGGI+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=TGGI
Basic Chart http://finance.yahoo.com/q/bc?s=TGGI+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=TGGI+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=TGGI+Headlines
Press Releases http://finance.yahoo.com/q/p?s=TGGI+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=TGGI+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=TGGI+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=TGGI+Industry
Major Holders http://finance.yahoo.com/q/mh?s=TGGI+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=TGGI+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=TGGI+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=TGGI
Balance Sheet http://finance.yahoo.com/q/bs?s=TGGI
Cash Flow http://finance.yahoo.com/q/cf?s=TGGI+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/TGGI
Market Watch http://www.marketwatch.com/investing/stock/TGGI
Bloomberg http://www.bloomberg.com/quote/TGGI:US
Morningstar http://quotes.morningstar.com/stock/s?t=TGGI
Bussinessweek http://investing.businessweek.com/research/st...icker=TGGI
Barchart http://www.barchart.com/quotes/stocks/TGGI
OTC Short Report http://otcshortreport.com/index.php?index=TGGI
Investopedia http://www.investopedia.com/markets/stocks/TGGI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading